Opendata, web and dolomites

Hy2Care

INJECTABLE HYDROGELS FOR CARTILAGE REPAIR

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "Hy2Care" data sheet

The following table provides information about the project.

Coordinator
HY2CARE BV 

Organization address
address: Drienerlolaan 5, ZH143
city: ENSCHEDE
postcode: 7522 NB
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website http://www.hy2care.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-06-01   to  2016-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    HY2CARE BV NL (ENSCHEDE) coordinator 50˙000.00

Map

 Project objective

Hy2Care BV is a spin-off company of Twente University, in the Netherlands. It is Hy2Care’s ambition to introduce the first cure to Osteoarthritis (OA). The World Health Organization forecasted that, without treatment, OA will be the fourth leading cause of disability by 2020. Today, there is still no adequate solution for more than 120 million patients worldwide. Therefore OA represents a major economic burden on individuals, health care and social care systems.

Hy2Care’s Injectable hydrogels are made out of advanced nanomaterials: During the gelation process the hydrogel is covalently bound to the surrounding cartilage and bone (a unique feature); as a consequence, integration of the repair tissue with the native cartilage is strongly improved. This unique tissue integration realized by the Hy2Care Injectable hydrogel discriminates it from all other products available on the market. The Injectable hydrogels are protected by a number of patent applications.

The joint and cartilage regeneration market is projected to rise to € 21.8 billion by 2019. Hy2Care’s material platform also has potential of wide-spread application in the biomedical field. Significant market opportunities have been identified in e.g. wound care (estimated market size of > € 10 billion), cell therapy (estimated market size of > € 10 billion), veterinary medicine (estimated market size of > € 1.5 billion). Also in the life sciences research and development market opportunities are identified.

The proposal relates to the work programme topic: Accelerating the uptake of nanotechnologies, advanced materials or advanced manufacturing and processing technologies by SMEs. The overall objective of Hy2Care’s innovation project is to produce Injectable hydrogels for cartilage repair. The objective of the feasibility study is to verify the technical, economical and practical viability of the hydrogel and to ensure successful market uptake throughout Europe/ Northern America.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HY2CARE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HY2CARE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

SUPPLEPRINT (2018)

Super Productive Line Printing Inkjet

Read More  

Volumizer (2018)

A natural, non-surgical, and safe facial filler which treats the root cause of facial ageing.

Read More  

HIL PT System (2017)

Revolutionary, cost effective, spatially efficient, proton therapy system for cancer treatment.

Read More